Convertible Notes Payable - Schedule of Interest Expenses (Details) - DiamiR Biosciences Corp. [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
May 31, 2025 |
May 31, 2024 |
|
| Schedule of Interest Expenses [Line Items] | ||
| Interest on notes | $ 38,508 | $ 23,232 |
| Amortization of discount | 43,538 | 25,367 |
| Total | $ 82,046 | $ 48,599 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate amount of interest paid or due on all long-term debt. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|